Navigation Links
EntreMed Reports Third Quarter 2013 Financial Results
Date:11/14/2013

ROCKVILLE, Md., Nov. 14, 2013 /PRNewswire/ -- EntreMed, Inc. (NASDAQ: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, today reported financial results for the three and nine-month periods ending September 30, 2013. 

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO )

EntreMed reported a net loss for the third quarter of 2013 of ($1.4 million), or ($0.05) per share. This compares with a net loss of ($1.2 million), or ($0.05) per share, for the same period last year.
For the first nine months of 2013 the reported net loss was ($4.4 million), or ($0.17) per share as compared to ($14.2 million), or ($0.81) per share for 2012.  The 2012 year to date reported net loss included non-cash interest charges associated with our financing in 2012 ($10.0 million for the nine months ended September 30, 2012).  Excluding this non-cash interest, net loss for the first nine months of 2012 was ($4.1 million), or ($0.23) per share.

As of September 30, 2013, EntreMed had cash and cash equivalents of approximately $15.9 million.

Sara B. Capitelli, EntreMed's Vice President, Finance & Principal Accounting Officer, commented on the third quarter results, "Our financial results for the third quarter are in line with our expectations.  Our research and development expenses for the third quarter increased compared to the previous year primarily due to costs associated with the Company's crossover bioavailability and food effect study of ENMD-2076, along with the clinical development of ENMD-2076 in China during 2013.  We anticipate fourth quarter operating expenses to increase as we execute on our clinical development plan in the US and China."

Dr. Ken
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. EntreMed Reports First Quarter 2012 Financial Results
2. EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
3. EntreMed Reports Second Quarter 2012 Financial Results
4. Dana-Farber Cancer Institutes Ursula A. Matulonis, MD Article on EntreMeds ENMD-2076 Published in the European Journal of Cancer
5. EntreMed Announces Publication Of Preclinical Results For ENMD-2076 In Triple-negative Breast Cancer
6. PNAS Publishes Preclinical Results of EntreMeds 2ME2 for Multiple Sclerosis
7. EntreMed Announces Initiation Of Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma
8. EntreMed To Raise $10.7 Million In Registered Direct Offering
9. EntreMed Reports Fourth Quarter And Year-End 2012 Financial Results And Business Outlook For 2013
10. EntreMed Announces Changes to Board of Directors and CEO Appointment
11. Patent Issued In U.S. For EntreMeds 2ME2 In Rheumatoid Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... -- Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO, ... from Mylan NV ("Mylan") (NASDAQ: MYL ) to ... $60.00 per share in cash and 2.2 Mylan ordinary ... The Board previously concluded that Mylan,s unsolicited ... and its future growth prospects and was not in ...
(Date:4/24/2015)... -- Bayer Corporation hosted its annual "Take Your Child to Work ... headquarters.  This is Bayer,s second "Take Your Child To Work ... campus, and Thursday,s event welcomed 230 children ready to see ... Fortunately, for the kids, this was not just another ... "Science For A Better Life," Bayer made sure that "Take ...
(Date:4/24/2015)... , April 24, 2015  IGI Laboratories, Inc. (NYSE ... based specialty generic pharmaceutical company, announced the Company will ... Tuesday, April 28, 2015 to discuss the 1st quarter ... listen to the call by dialing 1-888-346-3479. International participants ... should ask to be joined into the IGI Laboratories, ...
Breaking Medicine Technology:Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4
... Calif., March 31, 2011 NewCardio, Inc., (OTC Bulletin ... developer, announced today that the Company has been invited ... performance study at an upcoming conference entitled "Cardiovascular Safety ... Food and Drug Administration (FDA), the Cardiac Safety Research ...
... 31, 2011 The U.S. Department of Energy has ... field of medical technology and innovation for commercializing the ... agency, Dilon and similar entrepreneurs, "build the new industries ... our toughest global challenges." The Dilon 6800® ...
Cached Medicine Technology:NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 2NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 3NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 4NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 5NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development 6U.S. Department of Energy Hails Dilon Diagnostics as a Medical Technology Pioneer and Top National Innovator 2
(Date:4/27/2015)... (PRWEB) April 27, 2015 Winscribe ... to their suite of mobile speech productivity technology, ... iOS tablets and smartphones. , Winscribe ... Operating System since 2005. With the latest ... fourth generation mobile application interface in the last ...
(Date:4/27/2015)... Pure n Natural Systems, Inc. is pleased to ... at http://www.purennatural.com/ . The new website includes ... featured and sale items, as well as the official ... n Natural Systems’ website is designed to give customers ... neatly organized and provides plenty of useful information to ...
(Date:4/27/2015)... Aliso Viejo, CA (PRWEB) April 27, 2015 ... directly on top of footage with ProTelestrator from Pixel Film ... to draw a freehand sketch over a moving or still ... broadcasts to diagram and analyze sports plays or incoming weather ... "Animate Mode" checkbox and then adjust the frame slider to ...
(Date:4/27/2015)... Cambia Health Solutions is pleased to ... as Operating Partner within its Direct Health Solutions ... building companies that change the way people experience the ... be responsible for accelerating Cambia’s investments, which are focused ... economically sustainable and person-focused, while looking for new strategic ...
(Date:4/27/2015)... April 27, 2015 Doping has been ... Armstrong and Alex Rodriguez continue to capture the public’s ... a new frontier in performance enhancement along with new ... TV , accomplished neuroscientist Anjan Chatterjee of ... the ethics and dangers of these enhancements in sports. ...
Breaking Medicine News(10 mins):Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 2Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 3Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 4Health News:Pure n Natural Systems, Inc. Launches New Website Design 2Health News:Pure n Natural Systems, Inc. Launches New Website Design 3Health News:Pixel Film Studios releases ProTelestrator for Final Cut Pro X. 2Health News:Cambia Welcomes Ben Albert as Operating Partner 2Health News:Cambia Welcomes Ben Albert as Operating Partner 3Health News:The Brain, Smart Drugs, and Sports on SCI TV with Anjan Chatterjee 2Health News:The Brain, Smart Drugs, and Sports on SCI TV with Anjan Chatterjee 3
... Study says surgical advances may explain away the link ... News) -- Cataract surgery doesn,t hasten vision loss in ... conclusion of a new study that challenges the findings ... between cataract surgery and accelerated AMD progression. , AMD ...
... mouse model of human leukemia has provided critical insight into ... myeloid leukemia stem cells. The study, published by Cell Press ... Stem Cell , is likely to have a profound impact ... stem cells. , Leukemia stem cells (LSCs) were initially described ...
... Patient Advocate Foundation (NPAF) -- a national, non-profit organization ... patient access to health care through public policy reform ... Congress for passing and President Obama for signing the ... extend health coverage to four million uninsured American children. ...
... disease, A Su Salud revealed high incidence of diabetes, ... $55 million in free and low cost medical services ... -- CVS/pharmacy, the nation,s leading retail ... Salud" (To Your Health) health fairs, providing free health ...
... Montreal, Canada February 05, 2009 A ... who have received kidney transplants and compares them ... a significantly higher prevalence of psychiatric conditions (depression, ... adolescents who had undergone a transplant. The study ...
... recent survey of in-house,physician recruiters across the country ... on hospital systems throughout the United States, and,recruiting ... the lack,of physicians to fill key provider roles. ... from their most recent recruitment,and retention survey of ...
Cached Medicine News:Health News:Cataract Surgery Doesn't Worsen AMD 2Health News:Leukemia stem cells have more in common with embryonic stem cells than adult stem cells 2Health News:National Patient Advocate Foundation Applauds Congress' and President Obama's Decision to Extend Health Coverage to Four Million Uninsured Children 2Health News:CVS/pharmacy Launches 2009 'A Su Salud' Health Fairs Providing Free Health Screenings to the Community 2Health News:CVS/pharmacy Launches 2009 'A Su Salud' Health Fairs Providing Free Health Screenings to the Community 3Health News:Psychological impact found in adolescents with kidney transplants 2Health News:PracticeMatch: Healthcare Survey Defines Physician Recruitment Challenges 2
Full Handle Laseredge Slit Blade Knife, 3.0 mm angled bevel up. Blade tip dimension: 14.4 mm x 3.0 mm x 3.7 mm....
Full Handle Laseredge Slit Blade Knife, 2.85 mm slit. Blade tip dimension: 14.1 mm x 2.85 mm x 3.3 mm....
Full Handle Laseredge Slit Blade Knife, 2.65 mm angled double bevel. Blade tip dimension: N/A x 2.65 mm x N/A....
Full Handle Laseredge Slit Blade Knife, 2.65 mm angled bevel up. Blade tip dimension: 14.4 mm x 2.65 mm x 3.7 mm....
Medicine Products: